15% OFF $150+· CodeFALL15
Ends October 15Shop now
Lot certificates published
Discreet shipping

Compound monograph

ARA-290

Cibinetide is a synthetic peptide corresponding to a surface region of erythropoietin, characterized in the literature as a selective agonist at a heteromeric receptor complex distinct from the erythropoietin receptor homodimer.

Published: 2026-09-12Literature/identifier verification: 2026-08-23
ARA 290CibinetidaCibinetidumPHBSP

01

Identity & nomenclature

Cibinetide is a synthetic peptide corresponding to a surface region of erythropoietin, characterized in the literature as a selective agonist at a heteromeric receptor complex distinct from the erythropoietin receptor homodimer.

Cibinetide is the INN. The development code PHBSP appears in the PubChem synonym set and abbreviates pyroglutamate helix B surface peptide; the related designation HBSP (helix B surface peptide) is used in the literature for the same structural concept. The peptide corresponds to a surface region of the erythropoietin molecule that is not involved in erythropoietin receptor homodimer binding.

Declared aliases and development codes: ARA 290, Cibinetida, Cibinetidum, PHBSP.

02

Molecular properties

Molecular formulaC51H84N16O21
Molecular mass1257.3 Da
CAS Registry Number1208243-50-8
PubChem CID91810664
UNII9W5677JKDA

03

Structural characteristics

The source literature distinguishes two receptor arrangements: erythropoietin receptor homodimers, which mediate erythroid maturation, and heteromers of the erythropoietin receptor with the beta common receptor (CD131), termed the innate repair receptor. Cibinetide is described as a selective agonist at the latter that does not engage the homodimeric receptor, and therefore lacks the erythropoietic activity of erythropoietin itself.

04

Molecular targets & mechanisms

05

Analytical considerations

The molecular formula contains no sulfur, so sulfur-based oxidation pathways do not apply. Identity confirmation relies on mass and sequence-level methods.

06

Verified bibliography

  1. Cibinetide dampens innate immune cell functions thus ameliorating the course of experimental colitis.

    Nairz M, Haschka D, Dichtl S, Sonnweber T, Schroll A, Aßhoff M, Mindur JE, Moser PL, Wolf D, Swirski FK, Theurl I, Cerami A, Brines M, Weiss G

    Scientific reports · 2017-10-12 · Journal Article

    current
  2. Renoprotection and Mechanisms of Erythropoietin and Its Derivatives Helix B Surface Peptide in Kidney Injuries.

    Zhang Y, Chen W, Wu Y, Yang B

    Current protein & peptide science · 2017 · Review

    current

10

Methodology & citation verification

Reference identity is checked against official PubMed metadata. Local deterministic receipts bind each normalized title and canonical metadata record to its verification date. Scientific values remain absent when an authoritative source has not been verified.

Read the full methodology →